Research and Markets: North American Animal Health Regulations (2 Volumes).DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c79621) has announced the addition of North American North American named after North America. North American blastomycosis see North American blastomycosis. North American cattle tick see boophilusannulatus. Animal Health Regulations (2 Volumes) to their offering. "In the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. , there are three agencies that regulate animal health. It is important to understand this and to realize that for a non drug product, a different agency in the US may have jurisdiction and, consequently, approval power." This report, which has two volumes, is aimed at anyone who needs to understand the basics of animal health regulations in North America North America, third largest continent (1990 est. pop. 365,000,000), c.9,400,000 sq mi (24,346,000 sq km), the northern of the two continents of the Western Hemisphere. . Volume I looks at the legislative framework in place whilst Volume II concentrates on the practical side of submitting an application for market authorization The right or permission to use a system resource; the process of granting access. See access control. . Key coverage * Take a detailed look at the legislative and regulatory framework in place. * Understand how to bring an animal drug product to market in the US effectively and efficiently. * Use Volume 2 of the report as a practical guide taking you through the application processes - with invaluable do's and don'ts to help make a more favorable fa·vor·a·ble adj. 1. Advantageous; helpful: favorable winds. 2. Encouraging; propitious: a favorable diagnosis. 3. impression. * Find out the procedures for renewals, variations & extensions, generics and good practice guidelines practice guidelines Medical practice A set of recommendations for Pt management that identifies a specific or range of range of management strategies. See Peer review organization, Practice standards. Cf 'Cookbook' medicine. and more - providing you with a one stop resource. Key issues * Learn the roles of the three agencies regulating animal health in the US including, the US Department of Agriculture which regulates animal biological product, the US Environment Protection Agency which regulates pesticide pesticide, biological, physical, or chemical agent used to kill plants or animals that are harmful to people; in practice, the term pesticide is often applied only to chemical agents. products used on animals and the Food and Drug Administration (FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. ) regulates products considered to be animal drugs. * Find out the main acts and the FDA regulations as well as guidance on getting approvals and practical tips to speed up the approval process. * Volume I of the report looks closely at getting approval for generics products in the US. * Volume II guides you carefully through the intricacies of the pre-approval process, as well as the main application and any post-approval requirements. * Also included is them process at the Venter venter /ven·ter/ (ven´ter) pl. ven´tres [L.] 1. a fleshy contractile part of a muscle. 2. abdomen. 3. a hollowed part or cavity. ven·ter n. for Veterinary Medicine veterinary medicine, diagnosis and treatment of diseases of animals. An early interest in animal diseases is found in ancient Greek writings on medicine. Veterinary medicine began to achieve the stature of a science with the organization of the first school in the (CVM) for supplemental applications A Supplemental Application Is A Type Of Application Used By universities and Colleges From the State University Of New York(SUNY). The Supplemental Application is A common 2nd part of The 1st State-wide Application. to change or modify the original approved application. Chapters include: US Laws, US Pharmacopoeia pharmacopoeia or pharmocopeia (fär'məkəpē`ə), authoritative publication designating the properties, action, use, dosage, and standards of strength and purity of drugs. , FD regulations, FDA guidance documents and guidelines guidelines, n.pl a set of standards, criteria, or specifications to be used or followed in the performance of certain tasks. , access to US materials, generic products, regulatory process for generic animal drugs, approval requirements for the ANADA ANADA Abbreviated New Animal Drug Application , product variations permitted under the GADPTRA, filing new applications. Who should read this report? This report will be an ideal guide for: * Newcomers to the regulatory profession * Generics manufacturers in or outside of North America * Or drug developers wanting to market their products in North America. Chapter Outline: Volume 1 Chapter 1 Us Laws Chapter 2 FDA Regulations Chapter 3 FDA Guidance Documents And Guidelines Chapter 4 Access To Us Materials Chapter 5 Generic Products Chapter 6 Regulatory Process For Generic Animal Drugs Chapter 7 Approval Requirements For The Anada Chapter 8 Product Variations Permitted Under The Gadptra Volume 2 Chapter 1 The Compound Is Identified Chapter 2 Background Package And New Animal Drug Application Chapter 3 The Pre-Submission Conference Chapter 4 Protocol Submissions Chapter 5 Submission Of Data Chapter 6 Filing New Applications Chapter 7 Phased Reviews Chapter 8 Technical Sections Chapter 9 Review Of The Data Chapter 10 Approval Of Technical Sections And The New Animal Drug Application Chapter 11 Post Approval Requirements Chapter 12 Supplemental Applications Volume I In the United States, there are three agencies that regulate animal health products. The US Department of Agriculture regulates animal biological products, the US Environmental Protection Agency Environmental Protection Agency (EPA), independent agency of the U.S. government, with headquarters in Washington, D.C. It was established in 1970 to reduce and control air and water pollution, noise pollution, and radiation and to ensure the safe handling and regulates pesticide products used on animals and the Food and Drug Administration (FDA) regulates products considered to be animal drugs. It is important to understand this and to realise that for a non-drug product, a different agency in the US may have jurisdiction and, consequently, approval power. This report comes in two volumes. The first (current) volume takes a detailed look at the legislative and regulatory framework in place. These include the main acts and the FDA regulations. The FDA guidance on getting product approval is also outlined. Practical tips on how to access useful information on the regulatory side are given. This volume will help you understand how to bring an animal drug product to market in the US. The interactions needed to gain approval for an animal drug, the responsibilities a sponsor has post approval, and how the dossier can be modified to account for needed or desired changes following the initial application will all be explained. This volume also looks closely at getting an approval for generic products in the US. Also included is the process at the Center for Veterinary Medicine Center for Veterinary Medicine regulates the manufacture and distribution of food additives and drugs that will be given to animals. These include animals from which human foods are derived, as well as food additives and drugs for pet (or companion) animals. (CVM) for supplemental applications to change or modify the original approved application is described. Volume II In the United States, there are three agencies that regulate animal health products. The US Department of Agriculture regulates animal biological products, the US Environmental Protection Agency regulates pesticide products used on animals and the Food and Drug Administration (FDA) regulates products considered to be animal drugs. It is important to understand this and to realise that for a non-drug product, a different agency in the US may have jurisdiction and, consequently, approval power. This report has two volumes. Volume I looks at the legislative framework in place governing the acquisition of a market approval for a veterinary drug. This tome (Volume II) concentrates on the practical side of submitting an application for a market authorisation. The approval process is examined from the standpoint The Standpoint is a newspaper published in the British Virgin Islands. It was originally published under the name Pennysaver, largely as a shopping-coupon promotional newspaper, but since emerged as one of the most influential sources of journalism in the of a sponsor starting with a new chemical entity that is believed to have utility for an animal health need. This begins with the identification of a new compound and the development phase. The ensuing en·sue intr.v. en·sued, en·su·ing, en·sues 1. To follow as a consequence or result. See Synonyms at follow. 2. To take place subsequently. description focuses on a linear progression through the regulatory process in achieving approval to market the product in the US. The current volume explains what the Background Package is and its role in the pre-approval phase. The Background Package details for the Center for Veterinary Medicine reviewers what the sponsor knows about the molecule (chemical data). This includes literature that may exist, the potential claims the sponsor hopes to achieve, a preliminary outline of a plan of development, and even a draft label that the sponsor hopes to obtain. The explanation then moves on to the presubmission conference, where the CVM meets with the sponsor to discuss a development programme. This part of the two-volume report guides you carefully through the intricacies of the pre-approval process, as well as the main application and any post-approval requirements. For more information visit http://www.researchandmarkets.com/reports/c79621 Source: Informa Healthcare |
|
Printer friendly
Cite/link
Email
Feedback
Reader Opinion